Costco beats on earnings as membership fee hike boosts revenue

Costco beats on earnings as membership fee hike boosts revenue


A Costco Wholesale store in Connecticut.

Lindsey Nicholsonp | Getty Images

Costco on Thursday beat Wall Street’s quarterly earnings and sales estimates, as it got a boost in part from higher membership fees.

Here is how the warehouse club did for the fiscal first quarter compared to what Wall Street expected, according to a survey of analysts by LSEG:

  • Earnings per share: $4.04 vs. $3.79 expected
  • Revenue: $62.15 billion vs. $62.08 billion expected

In the three-month period that ended Nov. 24, Costco’s net income rose to $1.80 billion, or $4.04 per share, from $1.59 billion, or $3.58 per share in the year-ago period. Revenue increased from $57.80 billion in the year-ago period.

Costco has benefited from its reputation for selling bulk items at better value, as U.S. households feel the cumulative effect of higher food and housing prices. The membership-based club also hiked its annual membership fee for the first time in about seven years. The quarterly results are the first Costco has reported since that fee increase took effect in September.

Costco’s membership fee revenue came in at $1.17 billion, compared to the $1.16 billion Wall Street had expected.

Comparable sales for the company increased 5.2% year over year. In the U.S., comparable sales rose 5.2% as well.

E-commerce sales rose 13% in the quarter compared with the year-ago period.

As of Thursday’s close, shares of Costco are up nearly 50% so far this year, surpassing the 27% gains of the S&P 500 during the same period. Shares closed at $988.39 on Thursday.

This is breaking news. Please check back for updates.

Don’t miss these insights from CNBC PRO



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More